
|Videos|December 10, 2014
Developing a Standardized Set of Drug Interactions
Daniel C. Malone, RPh, PhD, FAMCP, details the process for developing a standardized set of drug interactions.
Advertisement
Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, details the process for developing a standardized set of drug interactions.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5

















































































































































































































